Oracle, Shares

Oracle Shares Under Pressure Amid Transparency Concerns and Debt Worries

22.01.2026 - 04:44:05

Oracle US68389X1054

Oracle Corporation finds itself navigating turbulent waters as legal challenges and balance sheet anxieties overshadow its narrative in the artificial intelligence sector. Investor sentiment has turned cautious, pressuring the stock price, following allegations that the company obscured the substantial capital requirements of its AI infrastructure expansion.

A class-action lawsuit filed by the Rosen Law Firm has catalyzed the recent sell-off. The core allegation centers on a lack of transparency, with the suit claiming Oracle failed to adequately inform investors about the true scale of investment needed to fund its aggressive push into AI. To fulfill massive cloud contracts, including a significant partnership with OpenAI, the company reportedly requires debt financing far exceeding initial communications.

Market observers now express concern that these escalating expenditures could threaten the firm's credit rating if rising debt levels breach thresholds required to maintain an "Investment Grade" status. These fears are reflected in the equity's performance: the stock now trades at a closing price of 165.90 euros, marking a decline of over 40% from its 52-week high recorded in September 2025.

Should investors sell immediately? Or is it worth buying Oracle?

Diverging Analyst Views in a Challenging Climate

The situation is compounded by a difficult macroeconomic backdrop. Reports of escalating trade tensions between the United States and the European Union have further dampened sentiment toward U.S. technology exporters. On Wall Street, analysts are divided in their assessment:

  • The Bull Case: Analysts at Guggenheim maintain a bullish price target of $400 U.S. dollars. Their primary rationale points to Oracle's massive backlog of $523 billion U.S. dollars, which they argue secures long-term revenue streams.
  • The Bear Case: Institutions including UBS and RBC Capital have taken a more cautious stance, reducing their price targets. They highlight significant execution risks and warn of the immense capital expenditure (CapEx) required to construct the necessary data center infrastructure.

The Core Investor Dilemma: Growth Versus Leverage

The fundamental conflict for shareholders remains unresolved. While Oracle boasts a record order backlog, the monetization of these contracts hinges on costly, debt-financed investments in hardware. Until the company's management provides a clearer and more transparent strategy regarding its capital structure, rebuilding investor confidence—particularly among bondholders—is likely to prove challenging.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from January 22 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 22.

Oracle: Buy or sell? Read more here...

@ boerse-global.de | US68389X1054 ORACLE